Exhibiting at VIV Asia 2025

Jinhe Biotechnology Co., Ltd. is a specialized Chinese veterinary pharmaceutical manufacturer focused on the research, production, and global supply of chlortetracycline-based products and anticoccidial feed additives. Based in Hohhot, Inner Mongolia, China, Jinhe Biotechnology is recognized for its high-quality antibiotic feed premixes, API production, and compliance with international safety and efficacy standards.

Company Background

Founded in 2004, Jinhe Biotechnology Co., Ltd. operates under the brand name Muxing, a name well-known in domestic and international markets for chlortetracycline-based veterinary solutions. With nearly two decades of industry experience, the company has built a strong foundation in fermentation-based antibiotic manufacturing and precision formulation for animal health.

The company operates a state-of-the-art production base in Hohhot with over 25,000 square meters of facility space, housing fermentation tanks, purification systems, and granulation lines dedicated to chlortetracycline hydrochloride and feed-grade formulations.

Core Business

Jinhe Biotechnology specializes in the development and manufacture of:

• Antibiotic APIs for veterinary use
• Medicated feed additives
• Anticoccidial agents for poultry

Their core product portfolio includes:

• Chlortetracycline Hydrochloride (CTC HCl) API
• CTC 20% Powder and 20% Granule for feed use
• Salinomycin Premix as a potent anticoccidial for broilers

Product and Service Offerings

Antibiotics

• Chlortetracycline Hydrochloride (CTC HCl): High-purity API for formulating veterinary medicinal products. Manufactured via fermentation, followed by rigorous purification and micronization processes.
• CTC 20% Powder and Granule: Feed-grade formulations for bacterial infections in poultry, swine, and cattle. Designed for high bioavailability and uniform mixing.

Anticoccidials

• Salinomycin Premix: Used in poultry feed to prevent and control coccidiosis caused by Eimeria species. Known for its potent ionophore action and low resistance development.

All products are manufactured in compliance with China Veterinary Drug GMP standards and are registered for export in multiple countries.

Unique Selling Proposition

Jinhe’s competitive strengths include:

• Fermentation-based production: Using advanced microbial strains to produce high-potency CTC with minimal residues.
• Formulation precision: Granules engineered for uniform dispersion and heat resistance during pelleting.
• High assay & purity levels: Chlortetracycline content consistently maintained above 95% for APIs and standardized 20% in feed-grade formulations.
• Global export compliance: Equipped to supply documentation, DMFs, and support for registration across regulated markets.

Their CTC formulations are widely preferred for their stability, efficacy, and consistent particle size, making them suitable for high-throughput feed mills.

Financials and Production Capacity

While Jinhe is a privately held enterprise, industry estimates suggest the company’s annual revenue exceeds USD 12–15 million, with more than 60% derived from international exports. The company’s capabilities include:

• Over 500 MT/year of Chlortetracycline API
• Over 5,000 MT/year of CTC feed premix (20% powder/granule)
• Salinomycin production capacity exceeding 1,000 MT/year

These volumes support both domestic and international bulk orders from large-scale integrators and feed manufacturers.

Shipment Records

According to verified data from platforms such as Volza and ImportYeti, Jinhe Biotechnology has fulfilled over 650 international shipments from 2020 to 2023. Top export destinations include Vietnam, Philippines, Indonesia, Bangladesh, Egypt, and Nigeria. Most shipments consist of:

• 25 kg drum or bag units
• Palletized containers for bulk customers

Shipment values typically range between USD 10,000 and USD 150,000, depending on volume and formulation.

Target Market

Jinhe serves a wide range of customers, including:

• Animal feed manufacturers and integrators
• Veterinary pharmaceutical formulators
• Distributors of veterinary active ingredients
• Government procurement programs for livestock health

Their products are particularly relevant for poultry and swine sectors, where bacterial infections and coccidiosis are major concerns.

Manufacturing and R&D Capabilities

Jinhe’s manufacturing base includes:

• Fermentation tanks ranging from 10 m³ to 50 m³
• Spray drying and granulation equipment
• In-house QC labs with HPLC, UV-spectrophotometry, and microbial testing instruments

The company maintains an R&D division focused on:

• Improving fermentation yield and purity
• Heat-stable and pelleting-tolerant granule formulations
• Resistance management strategies in anticoccidials

Collaborations with agricultural and veterinary research institutes help optimize clinical efficacy and formulation innovation.

Certifications and Compliance

• Veterinary Drug GMP Certification (China)
• ISO 9001:2015 Certified
• ISO 22000:2018 Food Safety Management
• Products are registered and compliant in 20+ export markets
• Full documentation available for CTC HCl API DMF filing and feed additive registration

All batches are accompanied by detailed COA, MSDS, and microbial contamination reports.

Customer Testimonials

“Jinhe's chlortetracycline granules maintain excellent flowability and heat stability. We’ve used them for over 3 years with consistent results.”
– Production Head, Feed Mill, Vietnam

“As a distributor, we value Jinhe’s technical documentation and batch consistency. Their products meet our market’s registration and efficacy demands.”
– Veterinary Distributor, Egypt

Major Achievements

• Exported to over 25 countries with growing global distribution network
• Recognized as a Top Antibiotic Feed Additive Manufacturer in Inner Mongolia
• Supported international partners in product registration and compliance processes
• Developed granulated CTC product with enhanced thermal stability up to 85°C
• Participated in major trade shows such as VIV China, CPhI China, and Asia Agri-Tech

Jinhe Biotechnology Co., Ltd. remains committed to animal health and sustainable livestock development through its reliable, science-based veterinary pharmaceutical products. With a focus on fermentation expertise, regulatory compliance, and international service, Jinhe is a preferred partner for customers seeking high-quality antibiotic APIs and feed additives.